C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/74 (2006.01) A61K 31/517 (2006.01) A61P 29/02 (2006.01) A61P 35/00 (2006.01) A61P 37/08 (2006.01) C07D 239/84 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 405/04 (2006.01) C07D 409/04 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2657200
The invention relates to compounds of the formula (I), which are appropriate for the treatment of kinase, e.g. PI3K-related, diseases, such as proliferative diseases, inflammatory diseases, obstructive airways disorders and transplantation related diseases.
La présente invention concerne des composés représentés par la formule (I), qui conviennent pour le traitement de pathologies liées à la kinase, par exemple des maladies associées à PI3K, telles que des maladies prolifératives, des maladies inflammatoires, des troubles obstructifs des voies respiratoires et des maladies liées aux transplantations-
Furet Pascal
Stauffer Frederic
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
2,4-substituted quinazolines as lipid kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-substituted quinazolines as lipid kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-substituted quinazolines as lipid kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1691604